230 related articles for article (PubMed ID: 21062980)
1. Hepatocyte nuclear factor-4alpha promotes gut neoplasia in mice and protects against the production of reactive oxygen species.
Darsigny M; Babeu JP; Seidman EG; Gendron FP; Levy E; Carrier J; Perreault N; Boudreau F
Cancer Res; 2010 Nov; 70(22):9423-33. PubMed ID: 21062980
[TBL] [Abstract][Full Text] [Related]
2. BCL9-2 promotes early stages of intestinal tumor progression.
Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
[TBL] [Abstract][Full Text] [Related]
3. Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice.
Barone M; Tanzi S; Lofano K; Scavo MP; Pricci M; Demarinis L; Papagni S; Guido R; Maiorano E; Ingravallo G; Comelli MC; Francavilla A; Di Leo A
Carcinogenesis; 2010 Feb; 31(2):269-74. PubMed ID: 19945967
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte nuclear factor 4α suppresses the aggravation of colon carcinoma.
Yao HS; Wang J; Zhang XP; Wang LZ; Wang Y; Li XX; Jin KZ; Hu ZQ; Wang WJ
Mol Carcinog; 2016 May; 55(5):458-72. PubMed ID: 25808746
[TBL] [Abstract][Full Text] [Related]
5. Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis.
Kress E; Skah S; Sirakov M; Nadjar J; Gadot N; Scoazec JY; Samarut J; Plateroti M
Gastroenterology; 2010 May; 138(5):1863-74. PubMed ID: 20114049
[TBL] [Abstract][Full Text] [Related]
6. Dietary carbohydrate source alters gene expression profile of intestinal epithelium in mice.
Wang B; Bobe G; LaPres JJ; Bourquin LD
Nutr Cancer; 2009; 61(1):146-55. PubMed ID: 19116885
[TBL] [Abstract][Full Text] [Related]
7. Expression of hepatocyte nuclear factor 4alpha in developing mice.
Kanazawa T; Konno A; Hashimoto Y; Kon Y
Anat Histol Embryol; 2009 Feb; 38(1):34-41. PubMed ID: 18803630
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis.
Hayhurst GP; Lee YH; Lambert G; Ward JM; Gonzalez FJ
Mol Cell Biol; 2001 Feb; 21(4):1393-403. PubMed ID: 11158324
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte nuclear factor 4alpha contributes to an intestinal epithelial phenotype in vitro and plays a partial role in mouse intestinal epithelium differentiation.
Babeu JP; Darsigny M; Lussier CR; Boudreau F
Am J Physiol Gastrointest Liver Physiol; 2009 Jul; 297(1):G124-34. PubMed ID: 19389805
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer.
Tanaka T; Jiang S; Hotta H; Takano K; Iwanari H; Sumi K; Daigo K; Ohashi R; Sugai M; Ikegame C; Umezu H; Hirayama Y; Midorikawa Y; Hippo Y; Watanabe A; Uchiyama Y; Hasegawa G; Reid P; Aburatani H; Hamakubo T; Sakai J; Naito M; Kodama T
J Pathol; 2006 Apr; 208(5):662-72. PubMed ID: 16400631
[TBL] [Abstract][Full Text] [Related]
11. Characterization of glucocorticoid receptor and hepatocyte nuclear factor 4alpha (HNF4alpha) binding to the hnf4alpha gene in the liver.
Bailly A; Briançon N; Weiss MC
Biochimie; 2009 Sep; 91(9):1095-103. PubMed ID: 19540905
[TBL] [Abstract][Full Text] [Related]
12. Convergence of Wnt signaling on the HNF4alpha-driven transcription in controlling liver zonation.
Colletti M; Cicchini C; Conigliaro A; Santangelo L; Alonzi T; Pasquini E; Tripodi M; Amicone L
Gastroenterology; 2009 Aug; 137(2):660-72. PubMed ID: 19454287
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical staining for P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha may complement mucin phenotype of differentiated-type early gastric carcinoma.
Takano K; Hasegawa G; Jiang S; Kurosaki I; Hatakeyama K; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2009 Jul; 59(7):462-70. PubMed ID: 19563409
[TBL] [Abstract][Full Text] [Related]
14. Construction of a plasmid vector for liver-specific inhibition of hepatocyte nuclear factor 4 alpha expression.
Song XQ; Chen EQ; Wang YB; Zhou TY; Liu L; Liu C; Cheng X; Tang H
Plasmid; 2012 Jan; 67(1):60-6. PubMed ID: 21907733
[TBL] [Abstract][Full Text] [Related]
15. Foxf2 in intestinal fibroblasts reduces numbers of Lgr5(+) stem cells and adenoma formation by inhibiting Wnt signaling.
Nik AM; Reyahi A; Pontén F; Carlsson P
Gastroenterology; 2013 May; 144(5):1001-11. PubMed ID: 23376422
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling of murine intestinal adenomas reveals early deregulation of multiple matrix metalloproteinase (Mmp) genes.
Martinez C; Bhattacharya S; Freeman T; Churchman M; Ilyas M
J Pathol; 2005 May; 206(1):100-10. PubMed ID: 15809971
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis.
Labbé E; Lock L; Letamendia A; Gorska AE; Gryfe R; Gallinger S; Moses HL; Attisano L
Cancer Res; 2007 Jan; 67(1):75-84. PubMed ID: 17210685
[TBL] [Abstract][Full Text] [Related]
18. Genes with aberrant expression in murine preneoplastic intestine show epigenetic and expression changes in normal mucosa of colon cancer patients.
Leclerc D; Lévesque N; Cao Y; Deng L; Wu Q; Powell J; Sapienza C; Rozen R
Cancer Prev Res (Phila); 2013 Nov; 6(11):1171-81. PubMed ID: 24169962
[TBL] [Abstract][Full Text] [Related]
19. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis.
Parviz F; Matullo C; Garrison WD; Savatski L; Adamson JW; Ning G; Kaestner KH; Rossi JM; Zaret KS; Duncan SA
Nat Genet; 2003 Jul; 34(3):292-6. PubMed ID: 12808453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
